5-(4'-(BROMOMETHYL)-[1,1'-BIPHENYL]-2-YL)-2-TRITYL-2H-TETRAZOLE, 95%, 1g

4-Bromo-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 1g

(3-METHYLAZETIDIN-3-YL)METHANOL HCL, 95.0%, 500mg

(R)-1-(3-NITROPHENYL)ETHAN-1-AMINE HCL, 95%, 1g

p-Nitrotoluène, min.98%, pour la synthèse, 100 g, emballage en verre

Ethyl 2-(2,4-difluorophenyl)thiazole-4-carboxylate, 95.0%, 250mg

Methyl 3-bromo-6-fluoropicolinate, 98%, 1g

N'-[1-Amino-2-p-tolylethylidine]hydrazinecarboxylic acid tert-butyl ester, 95.0%, 500mg

(1-Ethyl-1H-indazol-5-yl)boronic acid, 95.0%, 250mg

2,5-Bis(methoxycarbonyl)-3,4-diphenylcyclopentadienone5g

Ethyl 4-(2-bromophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate, 97%, 500mg

(2R,3S)-2-Amino-3-methoxybutanoic acid, 97%, 5g

2,5-Dimethyl-1H-pyrrole-3,4-dicarbaldehyde, 95%, 250mg